Skip to content

A study to see effect of Repetitive Transcranial Magnetic Stimulation (rTMS) in improving response in drug resistant OCD patients

A Study to Observe the Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) as an Augmentation Therapy in Pharmaco-resistant OCD - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063716
Enrollment
70
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F422- Mixed obsessional thoughts and acts

Interventions

Intervention1: Repetitive Transcranial Magnetic Stimulation (rTMS): Repetitive Transcranial Magnetic Stimulation (rTMS) will be applied for 6weeks to participants taken for study Control Intervention1

Sponsors

Dept of Psychiatry RNT Medical College and MB GOVERNMENT HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Response failure to previous or current use of medication or psychotherapy ( response failure was defined as scores more than 16 at Y BOCS despite atleast two SSRI trials of adequate dose and duration) 2. Stable medication regimen 8- 10 weeks before the intervention and unchanged during the treatment (4-6weeks)

Exclusion criteria

Exclusion criteria: 1. Previous treatment with electroconvulsive therapy, and presence or history of psychosis, substance abuse, suicide attempt and or active suicide ideation, neurological disorder, epilepsy, seizures, and head injury or loss of consciousness 2. According to the safety criteria for rTMS, patients with implanted devices, metal bodies, cardiac arrhythmia, unstable medical conditions, or pregnancy, were also excluded. 3. Patients diagnosed with any other comorbid psychiatric illness except depression and anxiety 4. Patients diagnosed with any other chronic physical illness

Design outcomes

Primary

MeasureTime frame
To observe the Effect of repetitive transcranial magnetic stimulation in YBOCS score in patients of pharmaco-resistant OCDTimepoint: After 25th session of rTMS

Secondary

MeasureTime frame
Changes in Y BOCS , HAM-A and HAM-D scoresTimepoint: After 10th , 15th and 20th session of rTMS

Countries

India

Contacts

Public ContactDr Rohit Yadav

RNT Medical College and MB Hospital

sureshgocher1981@gmail.com9468569813

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026